This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Boston Scientific has gained a duo of CE markings in the European Union (EU) for...
BD has announced a voluntary global recall of a single lot of ChloraPrep Clear 1...
EDX Medical has developed a new non-invasive prostate cancer test it hopes will ...
Johnson & Johnson is set to resume the limited market release of the Varipulse c...
A team from the University of Hong Kong has developed an AI-driven tool, CytoMAD...
As healthcare facilities grapple with staff shortages and rising patient demands...
Bio-Rad has entered a binding offer to purchase all equity interests in French b...
WhiteSwell has reported encouraging results from its DELTA-HF trial, which evalu...
FDA-Cleared Nanotechnology developed by Nanovis is planned for use to enhance Me...
Medical Device Network sits down with Professor David Leslie of the Alan Turing ...
GeneDX is set to launch ultrarapid whole genome sequencing (WGS) for neonatal an...
Allurion’s CEO confirmed to Medical Device Network that the company has changed ...
Yourgene Health, a molecular diagnostics group within the Novacyt group of compa...
InspireMD with NAMSA, is set to commence the study to assess the CGuard Prime 80...
Preventative health startup Prenuvo, which offers a full-body MRI scan technolog...
American companies Artera and Tempus are collaborating to expand access to Arter...
Medtronic will use the technology to develop PEEK interbody spine fusion devices...
Grail has partnered with Quest Diagnostics to enable access to its Galleri multi...
Newronika has completed a €13.6m ($14.1m) Series B funding to advance the develo...
QuantalX Neuroscience has gained the European CE Medical Device Regulation (MDR)...
Getinge intends to reallocate resources and focus on investing in more lucrative...
Thermo Fisher Scientific has launched the Invitrogen Evos S1000 spatial imaging ...
District Judge John Bates wrote the removals harm “everyday Americans, and most ...
Germitec has identified the US market opportunity to lead its aim of doubling ye...